AngioDynamics (ANGO) Competitors $9.57 -0.22 (-2.25%) Closing price 04:00 PM EasternExtended Trading$9.57 +0.00 (+0.05%) As of 05:42 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock ANGO vs. ATEC, IART, OFIX, SRDX, ARAY, RMTI, RSLS, ABT, ISRG, and BSXShould you be buying AngioDynamics stock or one of its competitors? The main competitors of AngioDynamics include Alphatec (ATEC), Integra LifeSciences (IART), Orthofix Medical (OFIX), Surmodics (SRDX), Accuray (ARAY), Rockwell Medical (RMTI), ReShape Lifesciences (RSLS), Abbott Laboratories (ABT), Intuitive Surgical (ISRG), and Boston Scientific (BSX). These companies are all part of the "health care equipment" industry. AngioDynamics vs. Alphatec Integra LifeSciences Orthofix Medical Surmodics Accuray Rockwell Medical ReShape Lifesciences Abbott Laboratories Intuitive Surgical Boston Scientific AngioDynamics (NASDAQ:ANGO) and Alphatec (NASDAQ:ATEC) are both small-cap medical companies, but which is the superior investment? We will contrast the two businesses based on the strength of their community ranking, earnings, institutional ownership, risk, analyst recommendations, media sentiment, profitability, valuation and dividends. Which has higher valuation & earnings, ANGO or ATEC? AngioDynamics has higher earnings, but lower revenue than Alphatec. AngioDynamics is trading at a lower price-to-earnings ratio than Alphatec, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioAngioDynamics$283.32M1.37-$184.35M-$1.01-9.45Alphatec$611.56M2.33-$186.64M-$1.14-8.68 Is ANGO or ATEC more profitable? Alphatec has a net margin of -31.06% compared to AngioDynamics' net margin of -79.38%. AngioDynamics' return on equity of -7.26% beat Alphatec's return on equity.Company Net Margins Return on Equity Return on Assets AngioDynamics-79.38% -7.26% -4.78% Alphatec -31.06%-541.39%-22.99% Does the MarketBeat Community prefer ANGO or ATEC? AngioDynamics received 35 more outperform votes than Alphatec when rated by MarketBeat users. Likewise, 61.26% of users gave AngioDynamics an outperform vote while only 58.06% of users gave Alphatec an outperform vote. CompanyUnderperformOutperformAngioDynamicsOutperform Votes37061.26% Underperform Votes23438.74% AlphatecOutperform Votes33558.06% Underperform Votes24241.94% Which has more volatility & risk, ANGO or ATEC? AngioDynamics has a beta of 0.52, indicating that its stock price is 48% less volatile than the S&P 500. Comparatively, Alphatec has a beta of 1.2, indicating that its stock price is 20% more volatile than the S&P 500. Does the media refer more to ANGO or ATEC? In the previous week, Alphatec had 4 more articles in the media than AngioDynamics. MarketBeat recorded 13 mentions for Alphatec and 9 mentions for AngioDynamics. AngioDynamics' average media sentiment score of 1.12 beat Alphatec's score of 0.84 indicating that AngioDynamics is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment AngioDynamics 4 Very Positive mention(s) 1 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Alphatec 6 Very Positive mention(s) 1 Positive mention(s) 3 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Do insiders and institutionals hold more shares of ANGO or ATEC? 89.4% of AngioDynamics shares are owned by institutional investors. Comparatively, 66.3% of Alphatec shares are owned by institutional investors. 5.4% of AngioDynamics shares are owned by insiders. Comparatively, 22.8% of Alphatec shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company is poised for long-term growth. Do analysts rate ANGO or ATEC? AngioDynamics presently has a consensus price target of $14.00, suggesting a potential upside of 46.75%. Alphatec has a consensus price target of $17.67, suggesting a potential upside of 78.63%. Given Alphatec's higher probable upside, analysts clearly believe Alphatec is more favorable than AngioDynamics.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score AngioDynamics 0 Sell rating(s) 0 Hold rating(s) 2 Buy rating(s) 0 Strong Buy rating(s) 3.00Alphatec 0 Sell rating(s) 1 Hold rating(s) 8 Buy rating(s) 0 Strong Buy rating(s) 2.89 SummaryAngioDynamics beats Alphatec on 10 of the 18 factors compared between the two stocks. Remove Ads Get AngioDynamics News Delivered to You Automatically Sign up to receive the latest news and ratings for ANGO and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart ANGO vs. The Competition Export to ExcelMetricAngioDynamicsSurgical & medical instruments IndustryMedical SectorNASDAQ ExchangeMarket Cap$387.39M$4.07B$5.32B$7.56BDividend YieldN/A39.50%5.11%4.33%P/E Ratio-1.6927.6221.7717.81Price / Sales1.3747.55378.2693.59Price / Cash2.4151.0838.1534.64Price / Book1.865.826.443.99Net Income-$184.35M$67.09M$3.20B$247.23M7 Day Performance6.00%5.89%6.42%7.24%1 Month Performance5.88%-3.03%-8.66%-6.26%1 Year Performance51.19%14.50%10.27%-0.18% AngioDynamics Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)ANGOAngioDynamics4.2359 of 5 stars$9.57-2.2%$14.00+46.3%+53.7%$388.61M$283.32M-1.70760Positive NewsATECAlphatec3.941 of 5 stars$10.18+4.4%$17.67+73.5%-23.5%$1.47B$611.56M-7.95700Analyst ForecastOptions VolumeNews CoverageIARTIntegra LifeSciences4.2664 of 5 stars$16.73-1.5%$22.71+35.8%-49.0%$1.29B$1.61B-185.873,720Short Interest ↓OFIXOrthofix Medical2.9048 of 5 stars$13.48-1.4%$23.33+73.1%+1.2%$526.02M$799.49M-4.311,090Gap DownSRDXSurmodics4.1704 of 5 stars$28.44-0.2%$50.00+75.8%+5.3%$406.58M$125.45M-28.16450Positive NewsARAYAccuray2.921 of 5 stars$1.51+3.4%N/A-33.8%$155.28M$453.14M-30.201,040News CoverageGap DownRMTIRockwell Medical4.1596 of 5 stars$1.05-1.4%$4.00+282.8%-34.7%$35.59M$101.49M-20.90300News CoverageNegative NewsGap DownRSLSReShape Lifesciences0.4377 of 5 stars$0.40-14.4%N/A-95.9%$4.46M$8.01M-0.0350Short Interest ↑ABTAbbott Laboratories4.8727 of 5 stars$127.78+0.7%$137.94+8.0%+17.1%$221.61B$41.95B16.70115,000Upcoming EarningsOptions VolumePositive NewsISRGIntuitive Surgical4.7968 of 5 stars$490.13-0.7%$611.86+24.8%+27.4%$174.57B$8.35B76.4612,100Upcoming EarningsPositive NewsBSXBoston Scientific4.4212 of 5 stars$94.20+0.6%$109.04+15.8%+38.4%$139.33B$16.75B75.3645,000Positive News Remove Ads Related Companies and Tools Related Companies Alphatec Competitors Integra LifeSciences Competitors Orthofix Medical Competitors Surmodics Competitors Accuray Competitors Rockwell Medical Competitors ReShape Lifesciences Competitors Abbott Laboratories Competitors Intuitive Surgical Competitors Boston Scientific Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:ANGO) was last updated on 4/15/2025 by MarketBeat.com Staff From Our Partners[Action Required] Claim Your FREE IRS Loophole GuideThis shouldn't surprise anyone who's been paying attention, but... Pres. Trump may be about to unleash the ...Colonial Metals | SponsoredGet Your Bank Account “Fed Invasion” Ready with THESE 4 Simple StepsStarting as soon as a few months from now, the United States government will make a sweeping change to bank ac...Weiss Ratings | SponsoredThe Trump Dump is starting; Get out of stocks now?The first 365 days of the Trump presidency… Will be the best time to get rich in American history.Paradigm Press | SponsoredElon Musk Confirms: Tesla’s Optimus is Replacing Workers… and Heading to MarsElon Musk just confirmed Tesla’s robot will go to Mars. But on Earth, it may trigger a trillion-dollar tech sh...InvestorPlace | SponsoredAmerica’s Retirement Accounts Are at Risk—Here’s WhyWhen Trump took office in 2017, gold was just $1,100 an ounce. By the time he left, it had soared to $1,839. ...Premier Gold Co | SponsoredCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | SponsoredTrump to redistribute trillions of dollars Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | SponsoredURGENT: This Altcoin Opportunity Won’t Wait – Act NowMy friends Joel and Adam have a simple motto: "For us, it's always a bull market." That’s because their 92%...Crypto Swap Profits | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding AngioDynamics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share AngioDynamics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy ANGO Stock Free ANGO Stock Alerts